Intestinal barrier integrity pathways

The intestinal barrier is a complex, dynamic system comprising a single layer of epithelial cells, tight junctions formed by proteins such as claudins, occludin, and zonula occludens, a mucus layer secreted by goblet cells, and immune components. Its integrity is vital for selectively permitting the absorption of nutrients, ions, and water while excluding toxins, bacteria, and antigens. Pathways controlling this barrier involve protein-protein interactions, cytoskeletal regulation, cellular signaling cascades (e.g., Nrf2 and AhR pathways), and immune responses. Loss of barrier integrity contributes to diseases such as inflammatory bowel disease, obesity, metabolic disorders, infection, and systemic inflammation[1][2][3][4]. Drugs that enhance barrier function often do so by upregulating tight junction proteins or dampening mucosal immune responses[4][2]. “Intestinal barrier integrity pathways” is a broad concept and not the name of a single target molecule; for structured target entries, refer to specific proteins like “Occludin”, “Claudin-4”, or “Zonula occludens-1”.\n\nThis entry is marked incorrect as it lacks target specificity and cannot be used as a canonical therapeutic target in databases designed for molecules or receptors.

Other names

Intestinal barrier functionIntestinal epithelial barrierGut barrier integrityIntestinal permeability pathways

Strengthening tight junction protein expression[4]\nInhibiting immune cell activation and inflammatory mediator release[2]